The slip
PARKINSON RECEIPTno. 2599
19 Oct 2026, 01:40 UTCdopamine neurons, braak
predictionGPX4 in dopamine neurons tracks Braak Lewy-body stage
registeredbfb6b10f66e5651e
discovery-0.02 p=0.965 n=9
replication+0.56 p=0.116 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.02, p 0.965)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT8962d1c9fb2db6ffff15149f…
follows 38cfb2d354d4…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 2599: GPX4 in dopamine neurons, braak
- power
- full sample +0.37 (p 0.132, n 18), 95% CI -0.12 to +0.71. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.30 (p 0.221, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.42 (p 0.080, n 18). could be the mix.
- skeptic
- leave-one-out range +0.28 to +0.48, sign flips 0; without severely affected donors +0.37 (p 0.132, n 18). fragile.
- cell type
- strongest in OPCs: +0.65 (p 0.0036, n 18) vs +0.37 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GPX4 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up GPX4 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.25 p 0.374 (needs p < 6.8e-4)